The Long RunClearing “zombie cells” improved scarred livers in a small trial
In a placebo-controlled trial in Amsterdam, the senolytic drug pair dasatinib and quercetin reduced liver scarring in people with fatty liver disease. The trial was small, and a larger one is needed.
Randomized trial in people